EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 20-Oct-2026 10:16 ET (20-Oct-2026 14:16 GMT/UTC)

Gladstone Institutes launches redesigned website, bringing cutting-edge bomedical research into focus

Gladstone Institutes
Business Announcement

Gladstone Institutes today announced the launch of its newly redesigned website, gladstone.org, offering a modernized, accessible platform that brings its biomedical research closer to the public, scientific community, and key partners.

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

Walter and Eliza Hall Institute
Peer-Reviewed Publication

A study led by researchers at WEHI (based in Melbourne, Australia) have found a previously overlooked type of immune cell can recognise and kill small cell lung cancer, revealing a new immune pathway for fighting the deadliest form of the disease.

Journal: Cancer Cell

What happens when brain tumors return? International study tracks genetic changes behind recurring cancers

Jackson Laboratory
Peer-Reviewed Publication

When patients are diagnosed with certain brain tumors, one of the biggest unanswered questions is what happens when the cancer returns. Among those are IDH-mutant gliomas, a group of brain tumors that invariably recur despite advances in treatment.

Journal: Nature

Neighborhood conditions linked to childhood cancer survivors’ long-term health

St. Jude Children's Research Hospital
Peer-Reviewed Publication

Discover how the St. Jude Lifetime Cohort Study uncovered community-level factors influencing chronic health condition risks, and how that can improve care.

Journal: EClinicalMedicine

When cancer cells are squeezed into tightly packed tumors, cancer stops spreading

Cell Press
Peer-Reviewed Publication

The growth and death of cancer cells in the lab is studied primarily in two-dimensional cell cultures. In a study publishing in the Cell Press journal Developmental Cell on October 14, researchers instead used three-dimensional models to uncover how pressure and mechanical confinement impact cell growth—halting the cells’ metastatic behavior and ultimately leading to their death. The findings could lead to the development of new biomarkers to predict which cancers are more likely to spread, or metastasize, and could ultimately lead to new approaches for preventing metastasis.

Journal: Developmental Cell
Funder: National Key Research and Development Program of China, CAS Youth Interdisciplinary Team, National Natural Science Foundation of China

ASH issues new recommendations to improve myelofibrosis care

American Society of Hematology
Peer-Reviewed Publication

(WASHINGTON – Oct. 14, 2026) – The American Society of Hematology (ASH) released guidelines on the management of myelofibrosis, a rare and life-threatening blood cancer. ASH’s new guidelines recommend expanded molecular testing, early transplant referral, appropriate use of JAK inhibitors, and aspirin therapy in select patients.

Journal: Blood Advances

Chemists develop blueprint for designing powerful fluorescent materials for better disease detection

University of Bath
Peer-Reviewed Publication

Scientists at the University of Bath (UK) have produced a new azulene-based fluorescent probe that is five times brighter than the original molecule. Their research has uncovered the tiny molecular changes needed to transform both the colour and brightness of the probes, paving the way for more powerful imaging tools for detecting diseases such as Alzheimer's, Parkinson’s and cancer.

Journal: Organic Chemistry Frontiers
Funder: Engineering and Physical Sciences Research Council, Henan Normal University

New study finds metastatic colorectal cancer’s immune defenses may begin outside the cancer cell, challenging view held for decades

University of South Florida
Peer-Reviewed Publication

Researchers at the University of South Florida, Tampa General Hospital and Hokkaido University have uncovered an important mechanism behind immune evasion in metastatic colorectal cancer (mCRC). The finding challenges a 30-year-old theory in cancer research and identifies a molecular pathway that offers a new target for treatment.

Journal: Journal of Experimental & Clinical Cancer Research
Funder: Tampa General Hospital Foundation, Japan society for the promotion of science KAKENHI

Scientists uncover overlooked mechanism driving aggressive leukemia

University of Nottingham
Peer-Reviewed Publication

Experts from the University of Nottingham have discovered how a common genetic mutation disrupts the positioning of a key protein during cell division, revealing a new mechanism behind acute myeloid leukaemia and a potential avenue for future treatment.

Acute myeloid leukaemia (AML) is an aggressive blood cancer that disrupts the production of healthy blood cells. Around one-third of patients carry a mutation in a gene called NPM1, which causes its protein to accumulate in the wrong part of the cell and plays a key role in driving the disease.

Until now, research has largely focused on how the mutated protein moves between the cell's nucleus and the surrounding cytoplasm. But a new study, led by Dr Daniel Booth and Dr Claire Seedhouse at the University of Nottingham's School of Medicine, reveals that what happens during cell division itself is also critical.

Journal: Nature

Researchers describe how a protein linked to cancer activates silent regions of DNA

Institute for Research in Biomedicine (IRB Barcelona)
Peer-Reviewed Publication

A team from IRB Barcelona, in collaboration with the Sant Joan de Déu Research Institute and the Pediatric Cancer Center Barcelona at Sant Joan de Déu Hospital, has described a mechanism by which a cancer-related protein can activate regions of DNA that normally remain silenced.

Using the Drosophila fruit fly, the researchers demonstrated that this activation depends on collaboration with another protein, enabling the study of a mechanism that is difficult to isolate in human cells.

The study, published in G3: Genes|Genomes|Genetics, may help explain previous observations in prostate cancer and B-cell acute lymphoblastic leukemia.

Journal: G3 Genes Genomes Genetics

4
5
6
7
8